Should I choose a telemedicine platform or work with a healthcare provider for GLP-1 therapy
Mounjaro (Tirzepatide) is highly effective for weight loss
Wegovy Now Available to Eligible Medicare Beneficiaries Through Medicare GLP-1 Bridge Nicholas Jacobus Key Takeaways Medicare GLP-1 Bridge provides Wegovy to eligible beneficiaries for $50/month through 2027, creating a defined access channel for obesity treatment previously largely excluded from Medicare coverage
Side effects observed in Phase 2 studies include nausea, vomiting, diarrhoea, decreased appetite, and injection-site reactions
Additionally, many people are unaware that the doses used in functional medicine are significantly lower than those associated with severe side effects
Politis SN, Mazurais D, Servili A, Zambonino-Infante J-L, Miest JJ, Srensen SR, et al